Jonathan Wolleben

Stock Analyst at JMP Securities

(4.65)
# 321
Out of 4,494 analysts
144
Total ratings
57.93%
Success rate
23.9%
Average return

20 Stocks

Madrigal Pharmaceuticals
Jul 16, 2024
Maintains: Market Outperform
Price Target: $381$385
Current: $279.13
Upside: +37.93%
Allakos
Jun 26, 2024
Reiterates: Market Outperform
Price Target: $3
Current: $0.75
Upside: +300.00%
Mirum Pharmaceuticals
Jun 18, 2024
Maintains: Market Outperform
Price Target: $66$68
Current: $37.37
Upside: +81.96%
Protagonist Therapeutics
Jun 17, 2024
Reiterates: Market Outperform
Price Target: $45
Current: $35.71
Upside: +26.02%
Sagimet Biosciences
Jun 7, 2024
Reiterates: Market Outperform
Price Target: $48
Current: $3.22
Upside: +1,390.68%
Crinetics Pharmaceuticals
Jun 4, 2024
Reiterates: Market Outperform
Price Target: $80
Current: $52.41
Upside: +52.64%
Larimar Therapeutics
May 31, 2024
Reiterates: Market Outperform
Price Target: $25
Current: $9.33
Upside: +167.95%
Structure Therapeutics
May 10, 2024
Reiterates: Market Outperform
Price Target: $91
Current: $37.90
Upside: +140.11%
Altimmune
May 10, 2024
Maintains: Market Outperform
Price Target: $25$24
Current: $6.55
Upside: +266.41%
Ocular Therapeutix
May 8, 2024
Maintains: Market Outperform
Price Target: $24$22
Current: $7.75
Upside: +183.87%
BioCryst Pharmaceuticals
May 7, 2024
Maintains: Market Outperform
Price Target: $14$15
Current: $7.05
Upside: +112.77%
Savara
May 6, 2024
Reiterates: Market Outperform
Price Target: $8
Current: $4.71
Upside: +69.85%
Rallybio
Apr 19, 2024
Reiterates: Market Outperform
Price Target: $8
Current: $1.30
Upside: +515.38%
Pharvaris
Apr 11, 2024
Maintains: Market Outperform
Price Target: $49$50
Current: $18.07
Upside: +176.70%
Spruce Biosciences
Mar 14, 2024
Maintains: Market Outperform
Price Target: $8$3
Current: $0.55
Upside: +449.45%
Clearside Biomedical
Mar 13, 2024
Reiterates: Market Outperform
Price Target: $5
Current: $1.15
Upside: +334.78%
Aura Biosciences
Nov 10, 2023
Maintains: Market Outperform
Price Target: $21$19
Current: $8.82
Upside: +115.42%
DBV Technologies
Aug 1, 2023
Reiterates: Market Outperform
Price Target: $8
Current: $0.83
Upside: +863.86%
ProQR Therapeutics
May 17, 2023
Reiterates: Market Outperform
Price Target: $6
Current: $1.80
Upside: +233.33%
Warner Music Group
May 12, 2023
Maintains: Outperform
Price Target: $25$24
Current: $32.17
Upside: -25.40%